Humacyte, Inc. · Brief

Next report

10 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

3 of 8≥ implied

Aug 13 '24±15.3%▲+0.53%×0.03

Nov 8 '24±14.9%▲+9.89%×0.66

Mar 28 '25±16.6%▼−2.49%×0.15

May 13 '25±16.3%▲+31.06%×1.90

Aug 11 '25±16.3%▼−29.64%×1.82

Q3 FY25±29.4%▼−2.34%×0.08

Q1 FY26±12.1%▼−19.42%×1.60

Q2 FY26±38.1%▼−6.34%×0.17

quarterimplied−40%0+40%realized×

Q2 FY26±38.1%▼−6.34%×0.17

Q1 FY26±12.1%▼−19.42%×1.60

Q3 FY25±29.4%▼−2.34%×0.08

Aug '25±16.3%▼−29.64%×1.82

May '25±16.3%▲+31.06%×1.90

Mar '25±16.6%▼−2.49%×0.15

2 older reports

Nov '24±14.9%▲+9.89%×0.66

Aug '24±15.3%▲+0.53%×0.03

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 11 report · est.

Bull2 of 3

4disclosed supplier and customer ties in SEC filingsSEC filings

167managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

5 of 8recent reports where the move came in under the options implied rangeEarnings history

4 of 20of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

HUMA report session

No linked exposure.

Oct 28impliedImplied move: ±27.1% into Nov 11 earnings (Oct 28 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.